
Kerstin Stenson
Director, Head and Neck Cancer Program · Rush University Medical Center
Credentials: · · · ·
History
- 2024–Present


1993–1994- 1989–1993
Otolaryngology
- 1988–1989
Research
Clinical Cancer Research · 2015 · 550 citations
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck
Journal of Clinical Oncology · 2003 · 480 citations
Annals of Oncology · 2004 · 288 citations

62 papers

55 papers

31 papers
- EB
30 papers

22 papers

21 papers · 2 as a resident

19 papers
- TS
17 papers
Clinical trials
- 2018–2022
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
Site PI · Unknown · Phase 2
MultiVir, Inc.


